Ampio Pharmaceuticals (AMPE) Stock Price, News & Analysis

Company Overview

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.

Key Stats

• Today's Range: $0.0029 to $0.0029
• 50-Day Range: $0.00 to $0.13
• 52-Week Range: $0.00 to $0.13
• Volume: 8 shs
• Average Volume: 694 shs
• Market Capitalization: $3.29 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AMPE Stock Analysis - Frequently Asked Questions

How have AMPE shares performed this year?

Ampio Pharmaceuticals' stock was trading at $0.0026 at the beginning of 2025. Since then, AMPE stock has increased by 11.5% and is now trading at $0.0029.

How were Ampio Pharmaceuticals' earnings last quarter?

Ampio Pharmaceuticals, Inc. (NYSE:AMPE) announced its quarterly earnings results on Wednesday, November, 10th. The company reported ($0.40) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.40).

When did Ampio Pharmaceuticals' stock split?

Ampio Pharmaceuticals shares reverse split on Tuesday, September 12th 2023.The 1-20 reverse split was announced on Thursday, August 31st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, September 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of Ampio Pharmaceuticals?

Shares of AMPE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Ampio Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Ampio Pharmaceuticals investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), CymaBay Therapeutics (CBAY), Trevena (TRVN), GE Aerospace (GE) and Catalyst Pharmaceuticals (CPRX).

Company Calendar

• Last Earnings: 11/10/2021
• Today: 8/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NYSE:AMPE
• CIK: 1411906
• Web: ampiopharma.com
• Phone: 720-437-6500
• Fax: 720-437-6501
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.04 per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 1,135,000
• Free Float: 1,098,000
• Market Cap: $3.29 thousand
• Optionable: No Data
• Beta: 4.76